Two case studies show how digital therapeutics can potentially treat neurological and neuropsychiatric conditions, areas where conventional therapeutics have encountered obstacles.

Researchers at St Jude Children's Research Hospital used high throughput screening (HTS) to identify SJ3149, a molecular glue degrader. This small molecule demonstrated efficacy across a range of cancer types.

Novo Nordisk and NVIDIA join forces to build an AI supercomputer which will be housed in Denmark's national centre for AI innovation.

Artificial Intelligence (AI) has significantly transformed high throughput screening (HTS) in drug discovery, increasing efficiency, accuracy, and predictive capabilities in early drug development stages. This research highlights AI's integration into HTS processes, showcasing improved outcomes in hit identification, assay optimization, and target validation, thus accelerating and refining the search for new medications.

Concise and insightful summaries of presentations delivered by prominent thought leaders at Discovery Europe 2023.

Concise and insightful summaries of presentations delivered by prominent thought leaders at Pharmaceutical Mobile Robotics 2023.

Concise and insightful summaries of presentations delivered by prominent thought leaders at SmartLabs Automation 2023.

Read how innovators are transforming the industry towards one that prioritizes both healthy patients and a healthy planet.

Iambic Therapeutics’ protein structure predictive model, NeuralPLexer2, surpasses AlphaFold2’s abilities.

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Machine learning model paves the way for predicting lung cancer.